CIPLA vs DRREDDY
Head-to-head DCF comparison · Cipla Limited vs Dr. Reddy's Laboratories Limited
Model Favors
DRREDDY shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
CIPLA
Cipla Limited
Pharma
₹1,383
Near Fair ValueDRREDDY
Dr. Reddy's Laboratories Limited
Pharma
₹1,276
Near Fair Value| Metric | CIPLA | DRREDDY |
|---|---|---|
| Verdict | Near Fair Value | Near Fair Value |
| YieldIQ Score | 45/100 | 55/100 |
| Fair Value | ₹1,218 | ₹1,519 |
| Current Price | ₹1,383 | ₹1,276 |
| Discount to FV | -11.9% | +19.0% |
| Moat | Narrow | Narrow |
| Piotroski F-Score | 5/9 | 4/9 |
| ROE | 11.3% | 11.4% |
| Debt / Equity | 0.02 | 0.21 |
| EV / EBITDA | 18.3× | 14.2× |
| Market Cap | ₹1.12 Lakh Cr | ₹1.06 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.